LARRY LAMBERTSON: Open Payments
NPI 1124019005 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$115,413 in 167 payments from 8 companies in 2025. Trend: 2023 $1,660 · 2024 $58,879 · 2025 $115,413
Speaker / faculty: $74,106Consulting: $27,305Travel & lodging: $10,587Food & beverage: $3,416
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 116 | $114,234 |
| Otsuka America Pharmaceutical, Inc. | 10 | $438 |
| Axsome Therapeutics, Inc. | 16 | $378 |
| ABBVIE INC. | 19 | $175 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $81 |
| Supernus Pharmaceuticals, Inc. | 3 | $55 |
| Alkermes, Inc. | 1 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: COBENFY, Auvelity, ABILIFY ASIMTUFII, ABILIFY MAINTENA, VRAYLAR, CAPLYTA, Qelbree, LYBALVI.
Industry payments across IN — which companies pay providers there.
